Skip to main content
Clinical Trials/CTRI/2022/09/045531
CTRI/2022/09/045531Not yet recruitingNot Applicable

"Comparison of analgesic effect of Clonidine as adjuvant with 0.35% concentration of Ropivacaine in USG guided thoracic Paravertebral block in modified radical Mastectomy: A prospective randomized double blind Study"

Department Of Anaesthesia RNT Medical College udaipur1 site in 1 country78 target enrollmentStarted: September 20, 2022Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
78
Locations
1
Primary Endpoint
DURATION OF ANALGESIA

Study Overview

Brief Summary

The purpose of this trial to find out minimum concentration of ropivacaine with clonidine for better Post operative analgesia in modified redical  mastectomy

Study Design

Study Type
Interventional
Allocation
Other
Masking
Double Blind Double Dummy

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Patients who are 18-60 year of age, ASA grade I and II, Normotensives or treated Hypertensives who will undergo MRM surgery will be included in the study.

Exclusion Criteria

  • Patient refusal,Patients with ASA III and higher,Patient having allergy to study drugs, Coagulation disorders,History of cardiovascular disease, Uncontrolled blood pressure,Pregnancy.

Outcomes

Primary Outcomes

DURATION OF ANALGESIA

Time Frame: up to 24 hrs after completion of surgery

Secondary Outcomes

  • THE RESCUE ANALGESIC REQUIREMENT(OVER FIRST 24 HRS POSTOPERATIVELY)

Investigators

Sponsor
Department Of Anaesthesia RNT Medical College udaipur
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials